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Abstract 
Male Wistar rats (15 weeks old), the ankle joints of one hindlimb of which were immobilized in the extended position for 12 days, were injected 
with salicylate as a trapping agent for hydroxyl radicals before sacrifice. Atrophied and contralateral soleus, typical slow red muscles were collected 
and their levels of 2,3-dihydroxybenzoic acid (2,3-DHB), one of the main reaction products formed by the attack of hydroxyl radical on salicylate, 
were determined using high-performance liquid chromatography with an electrochemical detector. There was a significant increase in 2,3-DHB in 
the atrophied muscle. This result strongly suggests the enhanced generation in vivo of hydroxyl radicals in atrophied muscle. 
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1. Introduction 
Oxidative stress causes free radical reactions, such as 
lipid peroxidation, which have a role in damaging bio- 
logical structures and cellular functions. It has been more 
than 10 years since exhaustive exercise was reported to 
increase oxidative stress in skeletal muscle, this being 
generally thought to be related to the pathogenesis of 
exercise myopathy [l]. Previously, we found that muscle 
atrophy induced by immobilization is also accompanied 
by oxidative stress; thiobarbituric acid-reactive sub- 
stance and oxidized glutathione were increased, and total 
glutathione was decreased in the atrophied muscle [2]. 
Moreover, in the same report, we proved that such oxi- 
dative stress accelerated muscle atrophy itself; vitamin E, 
an antioxidant, decreased the degree of atrophy. 
It is generally accepted that some transition metals, 
such as iron and copper, are imphicated in the produc- 
tion of free radicals [3]. We found an increased iron level, 
especially in microsomes in skeletal muscle atrophied by 
immobilization, and have suggested the possibility that 
increased iron may be responsible for the enhanced oxi- 
dative stress in atrophied muscle [4]. The role of iron has 
since been confirmed by the use of deferoxamine, an 
iron-chelating agent that was shown to suppress the in- 
creased oxidative stress [5]. 
Moreover, we suggested the increased levels of super- 
oxide anions and hydrogen peroxide in the cytoplasm of 
the atrophied muscle by showing the changes of antioxi- 
dant enzyme systems in atrophy [6]. Although they them- 
selves are not so reactive, the hydroxyl radical, the most 
aggressive of radicals, is known to be generated from 
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them through the catalytic function of iron [3]. There- 
fore, we suggested that hydroxyl radicals might be 
formed in atrophy from the increased superoxide anions 
and hydrogen peroxide in the cytoplasm and the in- 
creased iron in microsome [7]. 
Recently salicylate has been used as a trapping agent 
in an attempt to detect hydroxyl radicals in vivo [8-l 11. 
When small amounts of salicylate are added into a bio- 
logical system, its phenolic ring can be attacked by hy- 
droxyl radicals to yield dihydroxybenzoic acids (DHBs) 
[12], which can then be determined using high-perform- 
ance liquid chromatography (HPLC) [ 121. In the present 
investigation, to verify our suggestion described above, 
we measured the in vivo generation of hydroxyl radicals 
in atrophied muscle using the salicylate method. 
2. Materials and methods 
2. I. Animals 
Twelve male Wistar rats (15 weeks old) were used according to 
‘Guiding Principles in the Care and Use of Animals’. Under anaesthesia 
the ankle joint of one hindlimb was immobilized in the fully extended 
position (i.e. with the soleus muscle in a shortened position), as de- 
scribed previously [2]. The procedure for limb immobilization, as such, 
had no significant effects [4]. The period of immobilization was 12 days. 
Seven rats were injected intraperitoneally with salicylate 12 h before 
sacrifice. Salicylate was given in the form of sodium salt in a saline 
solution in a dose of 100 mg/kg b.wt. The other five rats were injected 
with a saline solution as placebo. 
After the 12-day immobilization, soleus, typical slow red muscles 
from both hindlimbs (atrophied and contralateral) were collected, the 
contralateral one being used as a control. The water contents of both 
muscles were the same, and we measured wet tissue weight instead of 
dry weight. The muscles were stored in liquid nitrogen until sample 
preparation. All samples were assayed within a week of collection. 
2.2. Reagents 
Special grades of 2,3-dihydroxybenzoic a id (2,3-DHB) and 2,5-dihy- 
droxybenzoic acid (2,5-DHB) were purchased from Tokyo Kasei 
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(Tokyo, Japan). Sodium sahcylate was from Nakalai Tesque (Kyoto, 
Japan). All other reagents were of the best grade available commer- 
cially. 
2.3. Measurement of 2,3-DHB 
The muscle was homogenized with a 5-fold vol. (w/v) of ice-cold 10% 
trichloroacetic acid under argon gas flow to lessen the oxidative-reduc- 
tive change. The homogenate was left to stand on ice for 20 min and 
centrifuged at 12,000 x g for 10 min. The supernatant was retained and 
directly injected into the HPLC system. 
The analytical procedure was a modification of the HPLC method 
of Davis et al. [13]. The HPLC system consisted of a solvent delivery 
system (Maltisolvent system 600E; Waters), an autoinjector (U6K; 
Waters), a column inlet filter (0.5 pm x 1.5 mm; Rheodyne), an ultravi- 
olet (UV) absorbance detector (Lambda-Max model 481; Waters), an 
electrochemical detector (ECD; Amperometer X375; IRICA, Japan), 
and computing integrators (D-2500; Hitachi: M741 data module; Wa- 
ters). Detection of peaks was at 240 nm for UV detection and at 0.6 V 
(applied potential) for ECD. The column was an Ultrasphere ODS 
(250 x 4.6 mm, 5 pm; Beckman), and the mobile phase was 5.0% aque- 
ous acetic acid with 2.0 g/l of ammonium acetate and 5.0 mg/l of EDTA 
(pH 3.0). The mobile phase was prepared daily, and kept anaerobic by 
bubbling with helium gas. The flow rate was 1.0 mUmin, and the in- 
jected volume was 40 ~1. Quantitation was based on peak heights of the 
ECD detector using external standards. 
Our preliminary results showed that the increased iron in atrophied 
muscles did not change the level of 2,3-DHB. We added 30 &g wet 
tissue of Fe2+ (which corresponded to the increased iron in atrophied 
muscle) to the homogenate of control soleus muscle and determined the 
level of 2,3-DHB. Consequently, this was not changed. 
2.4. Statistics 
The data were expressed as mean f S.E.M. A paired t-test was used 
for the comparison between atrophied and contralateral (control) mus- 
cles. 
3. Results 
The weight of soleus muscles varied from rat to rat, 
and so we calculated the ratio of atrophied-to-contra- 
lateral muscle weight. The ratios were 48.6 + 1.4 and 
48.3 f. 0.7% in rats with salicylate and placebo injection, 
respectively, and there was no significant difference in 
the degree of atrophy. Thus, salicylate had no effect on 
the progress of muscle atrophy. 
Representative chromatograms of ECD demonstrat- 
ing detection of 2,3-DHB, one of the main reaction prod- 
ucts formed by the attack of hydroxyl radicals on salicyl- 
ate, are presented in Fig. 1. As shown in Fig. lA, our 
HPLC system could clearly separate 2,3-DHB from 2,5- 
DHB, the other reaction product. The identity of peaks 
was determined by co-elution with an authentic standard 
and by comparison of the voltammogram with an au- 
thentic standard. As a result, one clearly separated peak 
was postulated as the 2,3-DHB peak in the chromato- 
gram of the muscle from the rat injected with salicylate, 
as demonstrated in Fig. 1B. In the chromatogram of the 
muscle from the rat injected with placebo, this peak was 
absent (refer to Fig. 1C). Therefore, this postulated peak 
in Fig. 1B was identified as 2,3-DHB. By contrast, our 
HPLC system could not completely separate the 2,5- 
DHB peak in atrophied muscles: an unknown peak over- 
lapped with that of 2,5-DHB, although it was very small 
compared with that of 2,SDHB. 
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Fig. 1. Representative HPLC-ECD chromatogram demonstrating de- 
tection of 2,3-dihydroxybenzoic acid (2,3-DHB) in 12-day atrophied 
soleus muscle. (A) Authentic standards for 2,5- and 2,3-DHB: the 
2,3-DHB peak is clearly separated from that of 2,5-DHB. (B) Extract 
of 12-day atrophied soleus from a rat injected with salicylate. The 
chromatogram demonstrated a clear peak of 2,3-DHB; the 2,5-DHB 
peak could not be separated. (C) Extract of l2-day atrophied soleus 
from a rat injected with placebo. The 2,3-DHB peak was absent (indi- 
cated by a star). 
The concentrations of 2,3-DHB were calculated using 
the peak height of ECD, and are presented in Fig. 2. The 
concentration of 2,3-DHB in the atrophied muscle was 
significantly higher than that of control muscle; its level 
increased more than four times during the 12-day atro- 
phy. 
4. Discussion 
The hydroxyl radical is one of the most reactive radi- 
cals and is thought to be frequently generated in biolog- 
ical systems. Although many methods have been devel- 
oped to measure it, the available methods with specificity 
are electron spin resonance-spin trapping and aromatic 
hydroxylation [12]. With the former is difficult to meas- 
ure the level of hydroxyl radicals in the in vivo system, 
since there is no proper spin trap. Alternatively, forma- 
tion of hydroxylated aromatic products is thought to be 
a favored reaction pathway under physiological condi- 
tions, and so formation of such products can be an index 
of hydroxyl radical generation in vivo. In particular, 
salicylate has been used the most of the aromatic prod- 
ucts; attack of hydroxyl radical on salicylate generates 
2,3-DHB and 2,5-DHB as major products [8-111. To 
measure DHBs in biological samples, recent investiga- 
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Fig. 2. Levels of 2,3-dihydroxybenzoic acid (2,3-DHB) in 1Zday atro- 
phied and contralateral (control) soleus muscles from rats injected with 
salicylate. Data are mean f S.E.M. (n = 7). *Significant difference at 
P < 0.05 compared with control. 
tors have come to use HPLC systems with UV detector 
or ECD [8-l 51. The levels of DHBs in the in vivo system 
were very low, probably because of their leakage from 
the cell. Hence, we used ECD detection in the quantita- 
tion of DHBs, since ECD detection is reported to be 
l,OOO-times more sensitive than UV detection [14]. In 
fact, it was very difficult to detect DHBs, especially 2,3- 
DHB, using UV detector in our experiments. 
The reliability of the salicylate method is dependent 
upon the specificity of DHBs for hydroxyl radicals. The 
group of Halliwell [15] demonstrated that 2,5-DHB 
could be produced by the cytochrome P-450 system in 
mammals by showing that microsomal fractions from 
mammals treated with inducers of cytochrome P-450 can 
produce 2,5-DHB but not 2,3-DHB, and, thus, they con- 
cluded that measurement of 2,5-DHB could give very 
misleading results. They recommended that 2,3-DHB is 
likely to be the main product of interest when using 
salicylate as a detector of hydroxyl radical generation, 
because 2,3-DHB was detected only when hydroxyl rad- 
ical formation was permitted [16]. According to their 
suggestion, we intended to investigate the change in the 
2,3-DHB levels. 
The salicylate-injection protocol such as ours has also 
been reported to maintain salicylate in tissues at a con- 
stant level, which was enough to trap hydroxyl radicals 
[9,17]. Taking these and the above discussions into con- 
sideration, the 2,3-DHB level in our experiments is 
thought to reflect the in vivo production of hydroxyl 
radicals. Therefore, the increase in 2,3-DHB in the pres- 
ent investigation strongly suggests the accelerating en- 
eration in vivo of hydroxyl radicals in skeletal muscle 
atrophied by immobilization. As far as we know, this is 
the first report demonstrating in the in vivo system the 
production of active oxygen species in atrophied muscle. 
Previously we suggested the increased generation of 
superoxide anion in the cytoplasm of atrophied muscle 
but not in the mitochondria by showing increased Cu- 
Zn-containing superoxide dismutase (Cu,Zn-SOD) and 
decreased Mn-containing superoxide dismutase [6], and 
reported the increased activity of superoxide-producing 
xanthine oxidase as the source of superoxide anion in the 
cytoplasm [7]. Enhanced production of superoxide ani- 
ons and increased Cu,Zn-SOD activity suggested the en- 
hanced production of hydrogen peroxide in the cyto- 
plasm. Due to the unchanged activities of Se-dependent 
glutathione peroxidase and catalase, which degrade 
hydrogen peroxide, the level of hydrogen peroxide was 
expected to be elevated in the cytoplasm of atrophied 
muscle [6]. This expectation was confirmed by the cyto- 
chemical study of hydrogen peroxide using short-term 
organ culture [7]. We reported increased microsomal 
iron in atrophied muscle [4] and since proved the impor- 
tant role of iron in oxidative stress [5]. It is generally 
known that hydroxyl radicals are generated from super- 
oxide anions and hydrogen peroxide in the presence of 
transition metals such as iron [3]. In view of the simulta- 
neous increase in microsomal iron and the increase in 
superoxide anions and hydrogen peroxide in the cyto- 
plasm, it was suggested that the generation of hydroxyl 
radicals might increase in atropied muscle [7]. The pres- 
ent investigation has confirmed this suggestion in the in 
vivo system and, consequently, strongly supports the 
mechanism of oxidative stress in muscle atrophy which 
has been presented in a series of our work. 
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